These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21325936)

  • 1. Herpesviridae viral infections after chemotherapy without antiviral prophylaxis in patients with malignant lymphoma: incidence and risk factors.
    Lee HS; Park JY; Shin SH; Kim SB; Lee JS; Lee A; Ye BJ; Kim YS
    Am J Clin Oncol; 2012 Apr; 35(2):146-50. PubMed ID: 21325936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
    Lyman GH; Delgado DJ
    Cancer; 2003 Dec; 98(11):2402-9. PubMed ID: 14635075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpesviridae viral infections following rituximab combined chemotherapy in patients with diffuse large B-cell lymphoma.
    Park LC; Lee HS; Shin SH; Im H; Ye BJ; Song MK; Oh SY; Lee SM; Lee WS; Kim YS
    Acta Haematol; 2011; 125(4):230-6. PubMed ID: 21325812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
    Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
    Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.
    Weycker D; Malin J; Kim J; Barron R; Edelsberg J; Kartashov A; Oster G
    Clin Ther; 2009 May; 31(5):1069-81. PubMed ID: 19539108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer.
    Sharma S; Rezai K; Driscoll D; Odunsi K; Lele S
    Gynecol Oncol; 2006 Oct; 103(1):181-5. PubMed ID: 16574203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors.
    Minisini A; Spazzapan S; Crivellari D; Aapro M; Biganzoli L
    Crit Rev Oncol Hematol; 2005 Feb; 53(2):125-31. PubMed ID: 15661563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option.
    Seropian S; Nadkarni R; Jillella AP; Salloum E; Burtness B; Hu GL; Zelterman D; Cooper DL
    Bone Marrow Transplant; 1999 Mar; 23(6):599-605. PubMed ID: 10217191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegfilgrastim primary prophylaxis in patients with non-Hodgkin lymphoma: results from an integrated analysis.
    Pettengell R; Schwenkglenks M; Bacon P; Lawrinson S; Duehrsen U
    Hematol Oncol; 2011 Dec; 29(4):177-84. PubMed ID: 21246591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of continuous, daily, oral, ultra-low-dose 200 mg acyclovir to prevent herpes zoster events among bortezomib-treated patients: a report from retrospective study.
    Aoki T; Nishiyama T; Imahashi N; Kitamura K
    Jpn J Clin Oncol; 2011 Jul; 41(7):876-81. PubMed ID: 21616919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutropenic complications in advanced-stage non-Hodgkin's lymphoma: implications for the use of prophylactic recombinant human granulocyte-colony stimulating factor (G-CSF).
    Bobey N; Woodman RC
    Clin Invest Med; 1998 Apr; 21(2):63-70. PubMed ID: 9562926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M; Thamlikitkul V
    J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
    Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
    J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of mortality in patients with cancer who experience febrile neutropenia.
    Lyman GH; Michels SL; Reynolds MW; Barron R; Tomic KS; Yu J
    Cancer; 2010 Dec; 116(23):5555-63. PubMed ID: 20715160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
    Cullen M; Steven N; Billingham L; Gaunt C; Hastings M; Simmonds P; Stuart N; Rea D; Bower M; Fernando I; Huddart R; Gollins S; Stanley A;
    N Engl J Med; 2005 Sep; 353(10):988-98. PubMed ID: 16148284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated longitudinal data on acute exacerbation of chronic hepatitis B in patients with breast cancer receiving anthracycline-based adjuvant chemotherapy: therapeutic vs. pre-emptive use of lamivudine.
    Sohn BS; Ahn JH; Jung KH; Ahn SH; Son BH; Gong G; Kim SB
    Jpn J Clin Oncol; 2011 Sep; 41(9):1059-66. PubMed ID: 21821601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma.
    Li YH; He YF; Jiang WQ; Wang FH; Lin XB; Zhang L; Xia ZJ; Sun XF; Huang HQ; Lin TY; He YJ; Guan ZZ
    Cancer; 2006 Mar; 106(6):1320-5. PubMed ID: 16470607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study.
    Offidani M; Corvatta L; Malerba L; Marconi M; Bichisecchi E; Cecchini S; Manso E; Principi T; Gasparini S; Leoni P
    Cancer; 2004 Aug; 101(3):567-77. PubMed ID: 15274070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, risk factors, and severity of herpesvirus infections in a cohort of 121 patients with primary dermatomyositis and dermatomyositis associated with a malignant neoplasm.
    Fardet L; Rybojad M; Gain M; Kettaneh A; Cherin P; Bachelez H; Dubertret L; Lebbe C; Morel P; Dupuy A
    Arch Dermatol; 2009 Aug; 145(8):889-93. PubMed ID: 19687419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.